staging
JLL Partners, Daniel Agroskin, private equity, merger, M&A
JLL closed its seventh fund at $1 bln in April 2016 New York sponsor looks to invest early in underlooked themes Recent exits in pharma services: Patheon, BioClinica Daniel Agroskin is a managing director at JLL Partners, where he leads the New York private equity firm’s healthcare efforts and is a member of the management committee. […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination